These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 9286960

  • 1. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin.
    Böger RH, Bode-Böger SM, Brandes RP, Phivthong-ngam L, Böhme M, Nafe R, Mügge A, Frölich JC.
    Circulation; 1997 Aug 19; 96(4):1282-90. PubMed ID: 9286960
    [Abstract] [Full Text] [Related]

  • 2. Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys.
    Dhawan V, Handu SS, Nain CK, Ganguly NK.
    Mol Cell Biochem; 2005 Jan 19; 269(1-2):1-11. PubMed ID: 15786711
    [Abstract] [Full Text] [Related]

  • 3. Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms.
    Böger RH, Bode-Böger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mügge A, Böhme M, Tsikas D, Frölich JC.
    Atherosclerosis; 1998 Nov 19; 141(1):31-43. PubMed ID: 9863536
    [Abstract] [Full Text] [Related]

  • 4. Dietary L-arginine normalizes endothelin-induced vascular contractions in cholesterol-fed rabbits.
    Phivthong-ngam L, Bode-Böger SM, Böger RH, Böhme M, Brandes RP, Mügge A, Frölich JC.
    J Cardiovasc Pharmacol; 1998 Aug 19; 32(2):300-7. PubMed ID: 9700994
    [Abstract] [Full Text] [Related]

  • 5. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production.
    Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich JC.
    Atherosclerosis; 1995 Oct 19; 117(2):273-84. PubMed ID: 8801873
    [Abstract] [Full Text] [Related]

  • 6. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits.
    Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC.
    Biochem Biophys Res Commun; 1996 Feb 15; 219(2):598-603. PubMed ID: 8605033
    [Abstract] [Full Text] [Related]

  • 7. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
    Bode-Böger SM, Böger RH, Kienke S, Böhme M, Phivthong-ngam L, Tsikas D, Frölich JC.
    Cardiovasc Res; 1998 Mar 15; 37(3):756-64. PubMed ID: 9659460
    [Abstract] [Full Text] [Related]

  • 8. Regression or progression. Dependency on vascular nitric oxide.
    Candipan RC, Wang BY, Buitrago R, Tsao PS, Cooke JP.
    Arterioscler Thromb Vasc Biol; 1996 Jan 15; 16(1):44-50. PubMed ID: 8548425
    [Abstract] [Full Text] [Related]

  • 9. Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fed rabbits.
    Srisawat S, Phivthong-Ngam L, Unchern S, Chantharaksri U, Govitrapong P, Sanvarinda Y.
    Clin Exp Pharmacol Physiol; 2003 Jan 15; 30(5-6):405-12. PubMed ID: 12859434
    [Abstract] [Full Text] [Related]

  • 10. L-arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix.
    Brandes RP, Brandes S, Böger RH, Bode-Böger SM, Mügge A.
    Life Sci; 2000 Jan 15; 66(16):1519-24. PubMed ID: 10794499
    [Abstract] [Full Text] [Related]

  • 11. Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits.
    Böger RH, Bode-Böger SM, Kienke S, Stan AC, Nafe R, Frölich JC.
    Atherosclerosis; 1998 Jan 15; 136(1):67-77. PubMed ID: 9544733
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits.
    Singer AH, Tsao PS, Wang BY, Bloch DA, Cooke JP.
    J Cardiovasc Pharmacol; 1995 May 15; 25(5):710-6. PubMed ID: 7630149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC.
    J Am Coll Cardiol; 1998 Nov 15; 32(5):1336-44. PubMed ID: 9809945
    [Abstract] [Full Text] [Related]

  • 19. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP.
    Circulation; 1998 Nov 03; 98(18):1842-7. PubMed ID: 9799202
    [Abstract] [Full Text] [Related]

  • 20. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.
    Behr-Roussel D, Rupin A, Simonet S, Bonhomme E, Coumailleau S, Cordi A, Serkiz B, Fabiani JN, Verbeuren TJ.
    Circulation; 2000 Aug 29; 102(9):1033-8. PubMed ID: 10961969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.